Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / SHS USD
-
Number of holders
-
323
-
Total 13F shares, excl. options
-
53.1M
-
Shares change
-
+2.24M
-
Total reported value, excl. options
-
$8.52B
-
Value change
-
+$372M
-
Put/Call ratio
-
0.72
-
Number of buys
-
165
-
Number of sells
-
-158
-
Price
-
$160.56
Significant Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q3 2014
388 filings reported holding JAZZ - Jazz Pharmaceuticals plc - SHS USD as of Q3 2014.
Jazz Pharmaceuticals plc - SHS USD (JAZZ) has 323 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 53.1M shares
.
Largest 10 shareholders include FMR LLC (8.65M shares), PUTNAM INVESTMENTS LLC (7.87M shares), VANGUARD GROUP INC (3.27M shares), JANUS CAPITAL MANAGEMENT LLC (3.19M shares), WESTFIELD CAPITAL MANAGEMENT CO LP (2M shares), LONE PINE CAPITAL LLC (1.79M shares), WELLS FARGO & COMPANY/MN (1.76M shares), BlackRock Institutional Trust Company, N.A. (1.42M shares), Westpac Banking Corp (1.39M shares), and BlackRock Fund Advisors (1.31M shares).
This table shows the top 323 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.